These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21905032)

  • 1. Stability of IgG1 monoclonal antibodies in intravenous infusion bags under clinical in-use conditions.
    Sreedhara A; Glover ZK; Piros N; Xiao N; Patel A; Kabakoff B
    J Pharm Sci; 2012 Jan; 101(1):21-30. PubMed ID: 21905032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags.
    Kumru OS; Liu J; Ji JA; Cheng W; Wang YJ; Wang T; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2012 Oct; 101(10):3636-50. PubMed ID: 22733600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Approach to Mitigate Particle Formation on the Dilution of a Monoclonal Antibody Drug Product in an IV Administration Fluid.
    Zheng S; Adams M; Mantri RV
    J Pharm Sci; 2016 Mar; 105(3):1349-50. PubMed ID: 26886343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical stability of pembrolizumab admixture solution in normal saline intravenous infusion bag.
    Sundaramurthi P; Chadwick S; Narasimhan C
    J Oncol Pharm Pract; 2020 Apr; 26(3):641-646. PubMed ID: 31446867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term stability of morphine hydrochloride in 0.9% NaCl infusion polyolefin bags after freeze-thaw treatment and in polypropylene syringes at 5 degrees C + 3 degrees C.
    Hecq JD; Godet M; Gillet P; Jamart J; Galanti L
    Int J Pharm Compd; 2014; 18(1):78-82. PubMed ID: 24881344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycation during storage and administration of monoclonal antibody formulations.
    Fischer S; Hoernschemeyer J; Mahler HC
    Eur J Pharm Biopharm; 2008 Sep; 70(1):42-50. PubMed ID: 18583113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A needle-free reconstitution and transfer system for compounded sterile intravenous drug solutions in compliance with United States Pharmacopeia Chapter <797> standards.
    Marks Z
    Int J Pharm Compd; 2014; 18(2):94-9. PubMed ID: 24881111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vented spikes improve delivery from intravenous bags with no air headspace.
    Galush WJ; Horst TA
    J Pharm Sci; 2015 Jul; 104(7):2397-400. PubMed ID: 25953689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-Use Stability of the Rituximab Biosimilar CT-P10 (Truxima
    Kim SJ; Kim KW; Shin YK; Kwon JW; Kang HY; Park YA; Shin JY; Kim SY; Han WY
    BioDrugs; 2019 Apr; 33(2):221-228. PubMed ID: 30747341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of telepharmacy and the use of a gravimetric technology-assisted workflow system for remote sterile product pharmacist checks.
    Jean SJ; Francart SJ; Eckel SF; Schenkat D; Eberwein S; Lamm M; Barnes N; Valgus JM; Amerine LB
    Am J Health Syst Pharm; 2020 Mar; 77(7):560-567. PubMed ID: 32086506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical and chemical stability of pemetrexed in infusion solutions.
    Zhang Y; Trissel LA
    Ann Pharmacother; 2006 Jun; 40(6):1082-5. PubMed ID: 16720706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability issues of parenteral chemotherapy drugs.
    de Lemos ML; Hamata L
    J Oncol Pharm Pract; 2007 Mar; 13(1):27-31. PubMed ID: 17621564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating.
    Martin M
    Int J Pharm Compd; 2018; 22(4):303-312. PubMed ID: 30021186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxics compounded sterile preparation control by HPLC during a 16-month assessment in a French university hospital: importance of the mixing bags step.
    Castagne V; Habert H; Abbara C; Rudant E; Bonhomme-Faivre L
    J Oncol Pharm Pract; 2011 Sep; 17(3):191-6. PubMed ID: 20630921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under in-use Conditions with Different Administration Materials.
    Mueller C; Dietel E; Heynen SR; Nalenz H; Goldbach P; Mahler HC; Schmidt J; Grauschopf U; Schoenhamnmer K
    Int J Pharm Compd; 2015; 19(3):261-7. PubMed ID: 26714367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical and biological stability of diluted vedolizumab in intravenous infusion bags.
    Hendrickx TCJ; Balcaen KDH; Baert M; Haustraete J; Lambrecht BN
    Eur J Hosp Pharm; 2024 Jan; ():. PubMed ID: 38212080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality Assurance and Quality Control, Part 2.
    Akers MJ
    Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevant shaking stress conditions for antibody preformulation development.
    Eppler A; Weigandt M; Hanefeld A; Bunjes H
    Eur J Pharm Biopharm; 2010 Feb; 74(2):139-47. PubMed ID: 19922795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput screening and stability optimization of anti-streptavidin IgG1 and IgG2 formulations.
    Alekseychyk L; Su C; Becker GW; Treuheit MJ; Razinkov VI
    J Biomol Screen; 2014 Oct; 19(9):1290-301. PubMed ID: 25023322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.